Pioglitazone suppressed IDD by inhibiting NF-κB [26], and our results showed the upregulation and activation of PPARγ protein could inhibit NF-κB in an IDD cell model. The gene discussed is PPARG; the disease is intervertebral disk degenerative disorder.